Loading cancer entity…
Loading cancer entity…
Clinical trials
29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (4)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04996849 | Contemporary Characteristics of Penile Cancer | terminated | — | 499 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT02837042 | Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma | terminated | Phase 2 | 6 | University of Alabama at BirminghamOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT02541903 |
| Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma |
| terminated |
| Phase 2 |
| 8 |
| University of Alabama at BirminghamOTHER |
| 1 |
| Apr 14, 2020 |
| clinicaltrials |
| NCT02279576 | Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)(PAZOPEN-SOGUG) | terminated | Phase 2 | 4 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Oct 14, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Sep 24, 2025source: clinicaltrials